Oneness Biotech Co., Ltd.

This study is testing an investigational drug called FB825 to see if it can help control moderate-to-severe allergic asthma in adults. About 100 participants will receive either the drug or a placebo via IV infusion over 24 weeks, while continuing their standard inhaler medicatio…

This study is testing an investigational drug called FB825, given as five injections under the skin, to see if it can help control moderate-to-severe atopic dermatitis (eczema). It will involve about 90 adults whose eczema hasn't responded well to standard creams. The main goal i…

This study is testing a new drug called FB704A to see if it is safe and can help control severe asthma. About 20 adults with severe asthma will receive either the drug or a placebo through an IV infusion over 8 weeks. Researchers will measure lung function, asthma symptoms, and q…

This is the first study in humans to check if a new drug called SNS851 is safe and how it moves through the body. It will involve 52 healthy adults who will receive injections under the skin. The main goal is to see what side effects occur and how well people tolerate the drug.